Journal Article
. 2013 Nov; 163(1):59-68.
doi: 10.1159/000355333.

Objectifying the conjunctival provocation test: photography-based rating and digital analysis

S Dogan 1 A Astvatsatourov  T M Deserno  F Bock  K Shah-Hosseini  A Michels  R Mösges  
Affiliations
  • PMID: 24248100
  •     8 citations

Abstract

Background: Patients with allergic rhinoconjunctivitis are susceptible to both nasal and ocular symptoms. The conjunctival provocation test (CPT) is an established diagnostic procedure used in allergic rhinoconjunctivitis, particularly to document a patient's current reactivity to allergens. To date, there are no international guidelines defining the CPT. No approved evaluation method exists for interpreting CPT results. This paper aims to establish the digital analysis of macroimages as an objective, validated and standardized method for interpreting CPT results.

Methods: In a clinical immunotherapy trial with 155 patients, treatment progress was documented based on the CPT. Local investigators used a symptom score to grade tearing, reddening and the patients' subjective perception of symptoms (mucosal irritation). A central observer rated conjunctival hyperemia via digital photography. Digital image analysis software was utilized to determine conjunctival hyperemia.

Results: Spearman's correlation between the local investigators' and the central observer's ratings was r = 0.729 (p < 0.001); the percentage of total agreement was 48% (based on 739 photos). Digital image analysis (based on 48 photos) had a high percentage of total agreement with the central observer's ratings (69%) but a low percentage of total agreement with the investigators' ratings (38%). The corresponding correlations were r = 0.264 and 0.064, respectively.

Conclusion: Photography-based rating by a central observer may represent a valuable supplement to the local investigator's assessment for making an objective evaluation of CPT results. Digital image analysis possesses the potential of being an objective evaluation method compared to the wide-spread subjective evaluation by the investigators.

A 12-week DBPC dose-finding study with sublingual monomeric allergoid tablets in house dust mite-allergic patients.
C Hüser, P Dieterich, +5 authors, R Mösges.
Allergy, 2016 Apr 14; 72(1). PMID: 27068870    Free PMC article.
Comparison between digital and optical microscopy: Analysis in a mouse gut inflammation model.
Airton Pereira E Silva, Sylvia Maria Nicolau Campos, Isabelle Mazza Guimarães, Gerlinde Agate Platais Brasil Teixeira.
Biomed Rep, 2017 Sep 13; 7(3). PMID: 28894572    Free PMC article.
A randomized, double-blind, placebo-controlled, dose-finding trial with Lolium perenne peptide immunotherapy.
R Mösges, E M Kasche, +10 authors, M H Shamji.
Allergy, 2017 Nov 19; 73(4). PMID: 29150857    Free PMC article.
Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B-cell response in seasonal allergic rhinitis patients.
R Mösges, A F Koch, +13 authors, M H Shamji.
Allergy, 2018 Jan 13; 73(6). PMID: 29322510    Free PMC article.
Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double-blind, placebo-controlled trial.
R Mösges, C Bachert, +10 authors, M H Shamji.
Allergy, 2018 Mar 08; 73(9). PMID: 29512827    Free PMC article.
Early nonreactivity in the conjunctival provocation test predicts beneficial outcome of sublingual immunotherapy.
Janina Köther, Alicia Mandl, +7 authors, Ralph Mösges.
Clin Transl Allergy, 2018 Jul 13; 8. PMID: 29997888    Free PMC article.
Validation of Computerized Quantification of Ocular Redness.
Ekaterina Sirazitdinova, Marlies Gijs, +3 authors, Thomas M Deserno.
Transl Vis Sci Technol, 2019 Dec 20; 8(6). PMID: 31853426    Free PMC article.
Liposomal Eye Spray Is as Effective as Antihistamine Eye Drops in Patients with Allergic Rhinoconjunctivitis Induced by Conjunctival Provocation Testing.
Anne-Nele Grzella, Sabine Schleicher, +4 authors, Ralph Mösges.
Int Arch Allergy Immunol, 2019 Mar 26; 179(2). PMID: 30909275    Free PMC article.